Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Compound was tested for it''s ability to inhibit binding of [125I]C5a radioligand to its receptor at a concentration of 1 to 10 uM; NS means no significant inhibition
Assay data:1 Tested
SummaryRelated BioAssays by Target
The compound was evaluated for its binding affinity against PAF receptor in human platelet
Assay data:3 Active, 3 Activity ≤ 1 nM, 3 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Displacement of [3H]PAF from PAF receptor of human platelet membranes
Assay data:15 Active, 15 Activity ≤ 1 µM, 15 Tested
Inhibition of platelet-activating factor binding at a concentration of 10 uM; Showed negligible activities
SummaryPubMed CitationRelated BioAssays by Target
Inhibitory activity against Platelet activating factor receptor using [3H]PAF at 10e5 (M)
Compound was tested for it''s ability to inhibit binding of [3H]-fMLP radioligand to its receptor at a concentration of 1 to 10 uM; NS means no significant inhibition
Compound was tested for it''s ability to inhibit binding of [3H]LTD4, radioligand to its receptor at a concentration of 1 to 10 uM; NS means no significant inhibition
Compound was tested for it''s ability to inhibit binding of [3H]LTC4, radioligand to its receptor at a concentration of 1 to 10 uM; NS means no significant inhibition
Compound was tested for it''s ability to inhibit binding of [3H]LTB4 radioligand to its receptor at a concentration of 1 to 10 uM; NS means no significant inhibition
The compound was evaluated for its binding affinity against PAF receptor in human platelet; Not determined
In vitro inhibition of [3H]-C18 PAF binding to human platelet membrane Platelet activating factor receptor was determined
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Compound was tested for it''s ability to inhibit [3H]C18-PAF binding to human platelet
Compound was tested for it''s ability to inhibit [3H]C18-PAF binding to PMN membrane receptors
Compound was evaluated for inhibition of binding of [3H]-C18 PAF to human platelet membrane Platelet activating factor receptor
Assay data:1 Active, 1 Activity ≤ 1 nM, 1 Activity ≤ 1 µM, 1 Tested
Tested in vitro for the inhibition of [3H]PAF receptor binding to washed human platelet membranes at a concentration of 10000 nM
Assay data:4 Tested
Tested in vitro for the inhibition of [3H]PAF receptor binding to washed human platelet membranes at a concentration of 1000 nM
In vitro inhibition of [3H]-C18 PAF binding to human platelet membrane Platelet activating factor receptor.
Assay data:21 Tested
Inhibition of PAF at 1 nM
Displacement of [3H]-PAF from PAF receptor at 1 to 3 uM
Displacement of [3H]-PAF from platelet activating factor receptor at 1 to 3 uM
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on